サマリー

肉腫治療薬の世界市場2022-2026年
Technavioは肉腫治療薬市場を監視しており、2022年から2026年の間に11億8000万ドルの成長が見込まれ、予測期間中にCAGR9％で進行しています。肉腫治療薬市場に関する当レポートでは、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、患者支援プログラム、戦略的提携の増加、新薬の上市によって牽引されています。さらに、患者支援プログラムは市場の成長をも押し上げると予想されます。
肉腫治療薬市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの肉腫治療薬市場は、以下のようにセグメント化されています。
タイプ別
- 軟部組織肉腫
- 骨肉腫
地域別状況
- 北米
- ヨーロッパ
- APAC
- その他の地域 (ROW)
本調査では、今後数年間における肉腫治療薬市場の成長を促進する主要な理由の一つとして、強力なパイプラインを挙げています。また、財政支援プログラムや償還制度、再生医療の登場は、同市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。肉腫治療薬市場に関する当レポートは、以下の分野を対象としています。
- 肉腫治療薬市場のサイジング
- 肉腫治療薬市場予測
- 肉腫治療薬市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Adaptimmune Therapeutics plc、Advenchen Laboratories LLC、Agenus Inc、Agios Inc、Bayer AG、Bristol Myers Squibb Co、CytRx Corp、Eisai Co.Ltd.、Epizyme Inc.、GlaxoSmithKline Plc、Johnson and Johnson Inc.、Karyopharm Therapeutics Inc.、Mirati Therapeutics Inc.、Novartis AG、PharmaMar SA、SillaJen Co.Ltd.、Athenex Inc.、Eli Lilly and Co.、およびPfizer Inc.が含まれています。また、肉腫治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sarcoma-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要な影響力を持つ人物を特定することで、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Soft tissue sarcoma - Market size and forecast 2021-2026
o Exhibit 28: Chart on Soft tissue sarcoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Soft tissue sarcoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Soft tissue sarcoma - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Soft tissue sarcoma - Year-over-year growth 2021-2026 (%)
o 5.4 Osteosarcoma - Market size and forecast 2021-2026
o Exhibit 32: Chart on Osteosarcoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Osteosarcoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Osteosarcoma - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Osteosarcoma - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 China - Market size and forecast 2021-2026
o Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Agios Inc.
o Exhibit 85: Agios Inc. - Overview
o Exhibit 86: Agios Inc. - Business segments
o Exhibit 87: Agios Inc. - Key offerings
o Exhibit 88: Agios Inc. - Segment focus
o 10.4 Athenex Inc.
o Exhibit 89: Athenex Inc. - Overview
o Exhibit 90: Athenex Inc. - Product / Service
o Exhibit 91: Athenex Inc. - Key offerings
o 10.5 Bayer AG
o Exhibit 92: Bayer AG - Overview
o Exhibit 93: Bayer AG - Business segments
o Exhibit 94: Bayer AG - Key news
o Exhibit 95: Bayer AG - Key offerings
o Exhibit 96: Bayer AG - Segment focus
o 10.6 Eisai Co. Ltd.
o Exhibit 97: Eisai Co. Ltd. - Overview
o Exhibit 98: Eisai Co. Ltd. - Business segments
o Exhibit 99: Eisai Co. Ltd. - Key offerings
o Exhibit 100: Eisai Co. Ltd. - Segment focus
o 10.7 Epizyme Inc.
o Exhibit 101: Epizyme Inc. - Overview
o Exhibit 102: Epizyme Inc. - Business segments
o Exhibit 103: Epizyme Inc. - Key offerings
o Exhibit 104: Epizyme Inc. - Segment focus
o 10.8 GlaxoSmithKline Plc
o Exhibit 105: GlaxoSmithKline Plc - Overview
o Exhibit 106: GlaxoSmithKline Plc - Business segments
o Exhibit 107: GlaxoSmithKline Plc - Key news
o Exhibit 108: GlaxoSmithKline Plc - Key offerings
o Exhibit 109: GlaxoSmithKline Plc - Segment focus
o 10.9 Johnson and Johnson Inc.
o Exhibit 110: Johnson and Johnson Inc. - Overview
o Exhibit 111: Johnson and Johnson Inc. - Business segments
o Exhibit 112: Johnson and Johnson Inc. - Key news
o Exhibit 113: Johnson and Johnson Inc. - Key offerings
o Exhibit 114: Johnson and Johnson Inc. - Segment focus
o 10.10 Karyopharm Therapeutics Inc.
o Exhibit 115: Karyopharm Therapeutics Inc. - Overview
o Exhibit 116: Karyopharm Therapeutics Inc. - Key offerings
o 10.11 Novartis AG
o Exhibit 117: Novartis AG - Overview
o Exhibit 118: Novartis AG - Business segments
o Exhibit 119: Novartis AG - Key offerings
o Exhibit 120: Novartis AG - Segment focus
o 10.12 PharmaMar SA
o Exhibit 121: PharmaMar SA - Overview
o Exhibit 122: PharmaMar SA - Business segments
o Exhibit 123: PharmaMar SA - Key news
o Exhibit 124: PharmaMar SA - Key offerings
o Exhibit 125: PharmaMar SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations

zzzz
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Soft tissue sarcoma - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Soft tissue sarcoma - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Soft tissue sarcoma - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Soft tissue sarcoma - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Osteosarcoma - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Osteosarcoma - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Osteosarcoma - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Osteosarcoma - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Agios Inc. - Overview
Exhibits86: Agios Inc. - Business segments
Exhibits87: Agios Inc. - Key offerings
Exhibits88: Agios Inc. - Segment focus
Exhibits89: Athenex Inc. - Overview
Exhibits90: Athenex Inc. - Product / Service
Exhibits91: Athenex Inc. - Key offerings
Exhibits92: Bayer AG - Overview
Exhibits93: Bayer AG - Business segments
Exhibits94: Bayer AG - Key news
Exhibits95: Bayer AG - Key offerings
Exhibits96: Bayer AG - Segment focus
Exhibits97: Eisai Co. Ltd. - Overview
Exhibits98: Eisai Co. Ltd. - Business segments
Exhibits99: Eisai Co. Ltd. - Key offerings
Exhibits100: Eisai Co. Ltd. - Segment focus
Exhibits101: Epizyme Inc. - Overview
Exhibits102: Epizyme Inc. - Business segments
Exhibits103: Epizyme Inc. - Key offerings
Exhibits104: Epizyme Inc. - Segment focus
Exhibits105: GlaxoSmithKline Plc - Overview
Exhibits106: GlaxoSmithKline Plc - Business segments
Exhibits107: GlaxoSmithKline Plc - Key news
Exhibits108: GlaxoSmithKline Plc - Key offerings
Exhibits109: GlaxoSmithKline Plc - Segment focus
Exhibits110: Johnson and Johnson Inc. - Overview
Exhibits111: Johnson and Johnson Inc. - Business segments
Exhibits112: Johnson and Johnson Inc. - Key news
Exhibits113: Johnson and Johnson Inc. - Key offerings
Exhibits114: Johnson and Johnson Inc. - Segment focus
Exhibits115: Karyopharm Therapeutics Inc. - Overview
Exhibits116: Karyopharm Therapeutics Inc. - Key offerings
Exhibits117: Novartis AG - Overview
Exhibits118: Novartis AG - Business segments
Exhibits119: Novartis AG - Key offerings
Exhibits120: Novartis AG - Segment focus
Exhibits121: PharmaMar SA - Overview
Exhibits122: PharmaMar SA - Business segments
Exhibits123: PharmaMar SA - Key news
Exhibits124: PharmaMar SA - Key offerings
Exhibits125: PharmaMar SA - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations